Asymptomatic hyponatremia precipitated by COVID-19 pneumonia

Abhinandan R. ChittalDepartment of Medicine, MedStar Health Internal Medicine Residency Program, Baltimore, MD, USACorrespondence[email protected]

Shiavax J. RaoDepartment of Medicine, MedStar Health Internal Medicine Residency Program, Baltimore, MD, USA

Pallavi LakraDepartment of Medicine, MedStar Health Internal Medicine Residency Program, Baltimore, MD, USA

Mary E. ZultyDepartment of Medicine, MedStar Health Internal Medicine Residency Program, Baltimore, MD, USA

References

Agarwal MA, Ziaeian B, Lavie CJ, et al. Cardiovascular disease in hospitalized patients with a diagnosis of coronavirus from the pre-COVID-19 era in USA: national analysis from 2016–2017. Mayo Clin Proc. 2020 Dec;95(12):2674–2683. Epub 2020 Sep 22. PMID: 33276839; PMCID: PMC7508501.
Web of Science ®Google Scholar
De La Flor JC, Marshall A, Biscotti B, et al. Hyponatremia in COVID-19 infection-should only think about SIADH? J Clin Nephrol Ren Care. 2020;6:057.
Google Scholar
Kazory A, Ronco C, McCullough PA. SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill. Proc (Bayl Univ Med Cent). 2020.Apr.16;1–6. PMID: 32336959; PMCID: PMC7171388. DOI:https://doi.org/10.1080/08998280.2020.1754700.
Google Scholar
Del Turco S, Vianello A, Ragusa R, et al. COVID-19 and cardiovascular consequences: is the endothelial dysfunction the hardest challenge? Thromb Res. 2020 Dec;196:143–151. Epub 2020 Aug 27. PMID: 32871306; PMCID: PMC7451195
Web of Science ®Google Scholar
Jg A-S, IJ N-G, Cuesta M, et al.; HOPE COVID-19 investigators. Prognostic impact of hyponatremia and hypernatremia in COVID-19 pneumonia. A HOPE-COVID-19 (health outcome predictive evaluation for COVID-19) registry analysis. Front Endocrinol (Lausanne). 2020 Nov 30;11:599255.
Web of Science ®Google Scholar